News
Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...
Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...
Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.
Switzerland's economic growth slowed sharply in the second quarter, as strong frontrunning of U.S. tariffs in the early part of the year unwound, raising the chance that the Swiss central bank will ...
Switzerland’s economy unexpectedly grew in the second quarter, maintaining some momentum before the country was hit with one of the highest US tariff rates.The expansion of 0.1% was better than the ...
Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...
The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...
President Trump's tariffs are starting to show up in economic data for the first time in a significant way. Wholesale ...
President Trump said he would unveil tariffs on semiconductor imports over the next couple of weeks as he prepares to expand his tariff agenda to different sectors. "I'll be setting tariffs next week ...
The disastrous outcome brought home Switzerland’s lack of leverage in an era of global instability and the misguidedness of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results